---
kind: "section"
citation: "21 C.F.R. § 522.2473"
title: "21"
number: "522.2473"
heading: "Tiludronate."
url: "https://uscodex.org/cfr/21/522.2473"
---

# §522.2473. Tiludronate.

- (a) **Specifications.** Each vial of powder contains 500 milligrams (mg) tiludronate disodium. Each milliliter of constituted solution contains 20 mg tiludronate disodium.
- (b) **Sponsor.** See No. 061133 in [§ 510.600(c)](/cfr/21/510.600.md?p=c) of this chapter.
- (c) **Conditions of use in horses—**
  - (1) **Amount.** Administer a single dose of 1 mg per kilogram (0.45 mg/pound) of body weight by intravenous infusion.
  - (2) **Indication for use.** For the control of clinical signs associated with navicular syndrome.
  - (3) **Limitations.** Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

## Notes

### Amendments

[79 FR 18159, Apr. 1, 2014, as amended at 82 FR 21691, May 10, 2017; 84 FR 8974, Mar. 13, 2019]

### Authority

Authority: 21 U.S.C. 360b.

### Source

Source: 40 FR 13858, Mar. 27, 1975, unless otherwise noted.

### Amendments

[79 FR 18159, Apr. 1, 2014, as amended at 82 FR 21691, May 10, 2017; 84 FR 8974, Mar. 13, 2019]